Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.
2.

BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis.

Sakamoto N, Feng Y, Stolfi C, Kurosu Y, Green M, Lin J, Green ME, Sentani K, Yasui W, McMahon M, Hardiman KM, Spence JR, Horita N, Greenson JK, Kuick R, Cho KR, Fearon ER.

Elife. 2017 Jan 10;6. pii: e20331. doi: 10.7554/eLife.20331.

3.
4.
5.

Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy.

Murcia O, Juárez M, Hernández-Illán E, Egoavil C, Giner-Calabuig M, Rodríguez-Soler M, Jover R.

World J Gastroenterol. 2016 Apr 7;22(13):3516-30. doi: 10.3748/wjg.v22.i13.3516. Review.

6.

Clinical significance of programmed death ligand-1 (PD-L1) in colorectal serrated adenocarcinoma.

Zhu H, Qin H, Huang Z, Li S, Zhu X, He J, Yang J, Yu X, Yi X.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9351-9.

7.

The Increasing Relevance of Tumour Histology in Determining Oncological Outcomes in Colorectal Cancer.

Nagtegaal ID, Hugen N.

Curr Colorectal Cancer Rep. 2015;11(5):259-266. Review.

8.

Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum.

Figueiredo JC, Crockett SD, Snover DC, Morris CB, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Robertson DJ, Burke CA, Bresalier RS, Church JM, Church TR, Baron JA.

Cancer Causes Control. 2015 Mar;26(3):377-86. doi: 10.1007/s10552-014-0513-0.

9.

Serrated polyps detected during screening colonoscopies.

Swiątkowski M, Meder A, Sobczyński L, Koza J, Szamocka M, Brudny J, Korenkiewicz J.

Contemp Oncol (Pozn). 2014;18(1):54-9. doi: 10.5114/wo.2014.40435.

10.

The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort.

Fernando WC, Miranda MS, Worthley DL, Togashi K, Watters DJ, Leggett BA, Spring KJ.

Gastroenterol Res Pract. 2014;2014:374926. doi: 10.1155/2014/374926.

11.

Serrated pathway in colorectal carcinogenesis.

Yamane L, Scapulatempo-Neto C, Reis RM, Guimarães DP.

World J Gastroenterol. 2014 Mar 14;20(10):2634-40. doi: 10.3748/wjg.v20.i10.2634. Review.

12.

Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT).

Heigh RI, Yab TC, Taylor WR, Hussain FT, Smyrk TC, Mahoney DW, Domanico MJ, Berger BM, Lidgard GP, Ahlquist DA.

PLoS One. 2014 Jan 20;9(1):e85659. doi: 10.1371/journal.pone.0085659.

13.
14.

Sessile serrated adenomas in the proximal colon are likely to be flat, large and occur in smokers.

Rustagi T, Rangasamy P, Myers M, Sanders M, Vaziri H, Wu GY, Birk JW, Protiva P, Anderson JC.

World J Gastroenterol. 2013 Aug 28;19(32):5271-7. doi: 10.3748/wjg.v19.i32.5271.

15.

Analysis of PTEN expression in large intestine polyps and its relation to the recognized histopathological and clinical risk factors for cancer development in this location.

Waniczek D, Snietura M, Pigłowski W, Rdes J, Kopeć A, Młynarczyk-Liszka J, Rudzki M, Hudyka K, Arendt J, Lange D.

Contemp Oncol (Pozn). 2012;16(4):310-5. doi: 10.5114/wo.2012.30059.

16.

Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.

Burnett-Hartman AN, Newcomb PA, Potter JD, Passarelli MN, Phipps AI, Wurscher MA, Grady WM, Zhu LC, Upton MP, Makar KW.

Cancer Res. 2013 May 1;73(9):2863-72. doi: 10.1158/0008-5472.CAN-12-3462.

17.

Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site.

Burnett-Hartman AN, Passarelli MN, Adams SV, Upton MP, Zhu LC, Potter JD, Newcomb PA.

Am J Epidemiol. 2013 Apr 1;177(7):625-37. doi: 10.1093/aje/kws282.

18.

Serrated pathway: alternative route to colorectal cancer.

Patai AV, Molnár B, Tulassay Z, Sipos F.

World J Gastroenterol. 2013 Feb 7;19(5):607-15. doi: 10.3748/wjg.v19.i5.607. Review.

19.

Serrated colon polyps as precursors to colorectal cancer.

Sweetser S, Smyrk TC, Sinicrope FA.

Clin Gastroenterol Hepatol. 2013 Jul;11(7):760-7; quiz e54-5. doi: 10.1016/j.cgh.2012.12.004.

20.

A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome.

Boparai KS, Dekker E, Polak MM, Musler AR, van Eeden S, van Noesel CJ.

Am J Pathol. 2011 Jun;178(6):2700-7. doi: 10.1016/j.ajpath.2011.02.023.

Items per page

Supplemental Content

Support Center